- Home
- Pharmaceuticals
- 040-000-278 Alfa-Lipoic Acid, CAS 1077-28-7
040-000-278 Alfa-Lipoic Acid, CAS 1077-28-7
Synonyms | 1,2-Dithiolane-3-pentanoic acid, 6,8-Dithiooctanoic acid, DL-α-Lipoic acid, DL-6,8-Thioctic acid |
Keywords | Anti-oxidation, herbal supplement, weight loss, headaches |
Related products | Biotin, Metformin (Hydrochloride), Retinoic Acid, Stearyl Glycyrrhetinate |
- Description
Description
Description
Specifications of Alfa-Lipoic Acid
Product Name | Alfa-lipoic acid |
CAS Registry Number | 1077-28-7 |
Molecular Formula | C8H14O2S2 |
Molecular Weight | 206.33 |
Purity | 98.0 % |
Melting point | 62 °C |
Appearance | Pale- yellow powder |
Solubility | Soluble in ethanol or methanol |
Shelf life | 2 years |
Storage | Easy to decompose at the light, should be sealed and protected from light |
Functions | Reduce blood glucose, treat weight loss, treat diabetic nerve pain, regulate NF-κB signal transduction |
Description of Alfa-Lipoic Acid
Alpha-lipoic acid is an antioxidant also known as Acetate Replacing Factor, ALA, Biletan, Lipoicin, Thioctan, and many other names.
Alpha-lipoic acid is a naturally occurring fatty acid that can be found in many foods such as yeast, spinach, broccoli, potatoes, and organ meats such as liver or kidney.
Alpha-lipoic acid is an antioxidant that is made naturally in the body and is also found in foods. It is used to break down carbohydrates and to make energy.
Applications of Alfa-Lipoic Acid
- Food additives
- Cosmetic raw material
- Active pharmaceutical ingredients
Reference:
- Component co-expression and purification of recombinant human pyruvate dehydrogenase complex from baculovirus infected SF9 cells Jiang Y, et al. Protein Expression and Purification 97, 9-16, (2014)
- Ameliorative role of antioxidant supplementation on sodium-arsenite induced adverse effects on the developing rat cerebellum Kaushal P, et al. Journal of Ayurveda and integrative medicine , -, (2019)
- Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial Ziegler D, et al. Diabetes Care 29(11), 2365-2370, (2006)
- Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid Moini H, et al. Toxicology and Applied Pharmacology 182(1), 84-90, (2002)